• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Tetraphase Pharmaceuticals Inc

+ Add to Watchlist

TTPH:US

25.8000 USD 1.7600 7.32%

As of 20:10:00 ET on 11/26/2014.

Snapshot for Tetraphase Pharmaceuticals Inc (TTPH)

Open: 24.0700 Day's Range: 24.0700 - 25.8670 Volume: 544,429
Previous Close: 24.0400 52wk Range: 8.0100 - 26.3400 1-Yr Rtn: +119.39%

Stock Chart for TTPH

No chart data available.
  • TTPH:US 25.8000
  • 1D
  • 1M
  • 1Y
24.0400
Interactive TTPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TTPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.2800
Est. EPS (USD) (12/2014) -2.3460
Est. PEG Ratio -
Market Cap (M USD) 790.96
Shares Outstanding (M) 30.66
30 Day Average Volume 608,516
Price/Book (mrq) 14.7609
Price/Sale (ttm) 81.9895
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TTPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TTPH

Tetraphase Pharmaceuticals, Inc. biopharmaceutical products. The Company offers antibiotics to treat multi-drug resistant bacterial infections. Tetraphase Pharmaceuticals serves customers in the United States.

Guy MacdonaldPresident/CEOJ Craig ThompsonChief Operating Officer
Patrick T HornChief Medical OfficerDavid C LubnerSenior VP/CFO
More Company Profile & Key Executives for TTPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil